Annual Total Liabilities
$32.49 M
-$34.74 M-51.68%
December 31, 2023
Summary
- As of March 11, 2025, FNCH annual total liabilities is $32.49 million, with the most recent change of -$34.74 million (-51.68%) on December 31, 2023.
- During the last 3 years, FNCH annual total liabilities has fallen by -$228.57 million (-87.56%).
- FNCH annual total liabilities is now -87.56% below its all-time high of $261.06 million, reached on December 31, 2020.
Performance
FNCH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$31.36 M
+$303.00 K+0.98%
June 30, 2024
Summary
- As of March 11, 2025, FNCH quarterly total liabilities is $31.36 million, with the most recent change of +$303.00 thousand (+0.98%) on June 30, 2024.
- Over the past year, FNCH quarterly total liabilities has stayed the same.
- FNCH quarterly total liabilities is now -87.99% below its all-time high of $261.06 million, reached on December 31, 2020.
Performance
FNCH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FNCH Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.7% | 0.0% |
| 3 y3 years | -87.6% | 0.0% |
| 5 y5 years | -80.1% | 0.0% |
FNCH Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -51.7% | +40.4% | -54.7% | +35.5% |
| 5 y | 5-year | -87.6% | +40.4% | -88.0% | +137.9% |
| alltime | all time | -87.6% | +40.4% | -88.0% | +137.9% |
Finch Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $31.36 M(+1.0%) |
| Mar 2024 | - | $31.05 M(-4.4%) |
| Dec 2023 | $32.49 M(-51.7%) | $32.49 M(-3.5%) |
| Sep 2023 | - | $33.68 M(-13.6%) |
| Jun 2023 | - | $38.96 M(-15.5%) |
| Mar 2023 | - | $46.09 M(-31.4%) |
| Dec 2022 | $67.23 M | $67.23 M(+0.2%) |
| Sep 2022 | - | $67.10 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $69.21 M(+178.6%) |
| Mar 2022 | - | $24.84 M(+7.3%) |
| Dec 2021 | $23.14 M(-91.1%) | $23.14 M(+75.6%) |
| Sep 2021 | - | $13.18 M(-40.5%) |
| Jun 2021 | - | $22.14 M(-16.5%) |
| Mar 2021 | - | $26.49 M(-89.9%) |
| Dec 2020 | $261.06 M(+60.1%) | $261.06 M |
| Dec 2019 | $163.10 M | - |
FAQ
- What is Finch Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Finch Therapeutics?
- What is Finch Therapeutics annual total liabilities year-on-year change?
- What is Finch Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Finch Therapeutics?
- What is Finch Therapeutics quarterly total liabilities year-on-year change?
What is Finch Therapeutics annual total liabilities?
The current annual total liabilities of FNCH is $32.49 M
What is the all time high annual total liabilities for Finch Therapeutics?
Finch Therapeutics all-time high annual total liabilities is $261.06 M
What is Finch Therapeutics annual total liabilities year-on-year change?
Over the past year, FNCH annual total liabilities has changed by -$34.74 M (-51.68%)
What is Finch Therapeutics quarterly total liabilities?
The current quarterly total liabilities of FNCH is $31.36 M
What is the all time high quarterly total liabilities for Finch Therapeutics?
Finch Therapeutics all-time high quarterly total liabilities is $261.06 M
What is Finch Therapeutics quarterly total liabilities year-on-year change?
Over the past year, FNCH quarterly total liabilities has changed by $0.00 (0.00%)